Axxcess Wealth Management LLC trimmed its holdings in shares of Danaher Co. (NYSE:DHR – Free Report) by 9.9% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 11,901 shares of the conglomerate’s stock after selling 1,308 shares during the quarter. Axxcess Wealth Management LLC’s holdings in Danaher were worth $2,732,000 at the end of the most recent reporting period.
Several other institutional investors also recently modified their holdings of DHR. Heck Capital Advisors LLC acquired a new position in shares of Danaher in the 4th quarter worth $27,000. Decker Retirement Planning Inc. acquired a new position in shares of Danaher in the 4th quarter valued at $31,000. Golden State Wealth Management LLC purchased a new position in Danaher in the 4th quarter worth about $31,000. Strategic Financial Concepts LLC acquired a new stake in Danaher during the 4th quarter worth about $31,000. Finally, Pineridge Advisors LLC lifted its stake in Danaher by 63.3% during the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock valued at $34,000 after buying an additional 57 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.
Insider Buying and Selling at Danaher
In related news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction dated Thursday, January 30th. The stock was sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at approximately $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Corporate insiders own 10.90% of the company’s stock.
Analyst Upgrades and Downgrades
Read Our Latest Analysis on DHR
Danaher Stock Performance
DHR opened at $212.71 on Wednesday. The stock has a 50-day moving average of $219.04 and a 200-day moving average of $239.67. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. Danaher Co. has a 52-week low of $196.80 and a 52-week high of $281.70. The company has a market cap of $152.03 billion, a PE ratio of 40.29, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82.
Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting the consensus estimate of $2.14. Danaher had a return on equity of 10.82% and a net margin of 16.33%. During the same quarter in the prior year, the firm earned $2.09 EPS. As a group, equities research analysts forecast that Danaher Co. will post 7.63 earnings per share for the current fiscal year.
Danaher Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be given a dividend of $0.32 per share. This is a positive change from Danaher’s previous quarterly dividend of $0.27. The ex-dividend date of this dividend is Friday, March 28th. This represents a $1.28 dividend on an annualized basis and a yield of 0.60%. Danaher’s payout ratio is currently 24.24%.
Danaher Profile
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- Golden Cross Stocks: Pattern, Examples and Charts
- Arqit Stock Soars as NVIDIA’s GTC Fuels Quantum Excitement
- There Are Different Types of Stock To Invest In
- 3 Must-Own Stocks to Build Wealth This Decade
- Election Stocks: How Elections Affect the Stock Market
- Advanced Micro Devices Eyes AI Market Growth—Is AMD a Buy?
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR – Free Report).
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.